Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis
暂无分享,去创建一个
[1] A. Marette,et al. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. , 2005, Endocrinology.
[2] E. Hafen,et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.
[3] Cristina M Rondinone,et al. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. , 2004, Biochemical and biophysical research communications.
[4] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[5] Lewis C Cantley,et al. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. , 2005, Genes & development.
[6] D. Kwiatkowski,et al. Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation , 2002, The Journal of Biological Chemistry.
[7] D. James,et al. Intracellular Localization of Phosphatidylinositide 3-kinase and Insulin Receptor Substrate-1 in Adipocytes: Potential Involvement of a Membrane Skeleton , 1998, The Journal of cell biology.
[8] L. Aicher,et al. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. , 2002, Cancer research.
[9] L. S. Harrington,et al. Restraining PI3K: mTOR signalling goes back to the membrane. , 2005, Trends in biochemical sciences.
[10] Hongbing Zhang,et al. Tsc2 Null Murine Neuroepithelial Cells Are a Model for Human Tuber Giant Cells, and Show Activation of an mTOR Pathway , 2002, Molecular and Cellular Neuroscience.
[11] M. White,et al. Nutrient-dependent and Insulin-stimulated Phosphorylation of Insulin Receptor Substrate-1 on Serine 302 Correlates with Increased Insulin Signaling* , 2004, Journal of Biological Chemistry.
[12] M. White,et al. c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade* , 2003, The Journal of Biological Chemistry.
[13] W. Cavenee,et al. IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation , 2000, Oncogene.
[14] Hongbing Zhang,et al. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma , 2003, The Lancet.
[15] M. Birnbaum,et al. Protein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101* , 2004, Journal of Biological Chemistry.
[16] K. Inoki,et al. Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity , 2004, Molecular and Cellular Biology.
[17] M. White,et al. Signaling Pathways: The Benefits of Good Communication , 2004, Current Biology.
[18] Johan Auwerx,et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.
[19] G. Thomas,et al. Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. , 2002, Genes & development.
[20] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[21] T. Hunter,et al. Critical Role of T-Loop and H-Motif Phosphorylation in the Regulation of S6 Kinase 1 by the Tuberous Sclerosis Complex* , 2004, Journal of Biological Chemistry.
[22] O. Shah,et al. Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids. , 2000, The Biochemical journal.
[23] D. Sabatini,et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.
[24] Gordon B Mills,et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. , 2006, Cancer research.
[25] Joseph Avruch,et al. Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.
[26] D. Sabatini,et al. Structure of S6 Kinase 1 Determines whether Raptor-mTOR or Rictor-mTOR Phosphorylates Its Hydrophobic Motif Site*♦ , 2005, Journal of Biological Chemistry.
[27] A. Hodges,et al. Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent , 2002, The Journal of cell biology.
[28] C. Kahn,et al. Dynamics of Insulin Signaling in 3T3-L1 Adipocytes , 1998, The Journal of Biological Chemistry.
[29] T. Hunter,et al. Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.
[30] T. Hunter,et al. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. , 1991, Methods in enzymology.
[31] R. DePinho,et al. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. , 2004, Genes & development.
[32] I. Gout,et al. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.
[33] T. Hunter,et al. Tuberous Sclerosis and Insulin Resistance: Unlikely Bedfellows Reveal A TORrid Affair , 2005, Cell cycle.
[34] B. Edgar,et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins , 2003, Nature Cell Biology.
[35] R. Poulsom,et al. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. , 2002, Cancer research.
[36] D. James,et al. Release of Insulin Receptor Substrate Proteins from an Intracellular Complex Coincides with the Development of Insulin Resistance* , 2000, The Journal of Biological Chemistry.
[37] P. Worley,et al. Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells , 2002, Oncogene.
[38] Hongbing Zhang,et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. , 2003, The Journal of clinical investigation.
[39] G. Romano,et al. Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells , 2001, Oncogene.
[40] T. Haruta,et al. Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin , 2001, Molecular and Cellular Biology.
[41] Hongbing Zhang,et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. , 2002, Human molecular genetics.
[42] P. Pandolfi,et al. Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. , 2005, Genes & development.
[43] F. Tamanoi,et al. Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation , 2004, Glia.
[44] J. Tanti,et al. MAP kinases and mTOR mediate insulin-induced phosphorylation of Insulin Receptor Substrate-1 on serine residues 307, 612 and 632 , 2003, Diabetologia.
[45] Alexandros Tzatsos,et al. Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation , 2006, Molecular and Cellular Biology.
[46] J. Blenis,et al. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.